SEARCH

SEARCH BY CITATION

References

  • Allen, G.C., Cattran, C.B., Peterson, R.G. and Lalande, M. (1988) Plasma levels of dantrolene following oral administration in malignant hyperthermia-susceptible patients. Anesthesiol. 69, 900-904.
  • Chan, C.H. (1990) Dantrolene sodium and hepatic injury. Neurol. 40, 1427-1432.
  • Court, M.H., Engelking, L.R., Dodman, N.H., Anwer, M.S., Seeler, D.C. and Clark, M. (1987) Pharmacokinetics of dantrolene sodium in horses. J. vet. Pharmacol. Therap. 10, 218-226.
  • Dranchak, P.K., Valberg, S.J., Onan, G.W., Gallant, E.M., MacLeay, J.M., McKenzie, E.C., De La Corte, F.D., Ekenstedt, K. and Mickelson, J.R. (2005) Inheritance of recurrent exertional rhabdomyolysis in thoroughbreds. J. Am. vet. med. Ass. 227, 762-267.
  • Edwards, J.G.T., Newton, J.R., Ramzan, P.H.L., Pilsworth, R.C. and Shepherd, M.C. (2003) The efficacy of dantrolene sodium in controlling exertional rhabdomyolysis in the Thoroughbred racehorse. Equine vet. J. 35, 707-710.
  • Firshman, A.M., Valberg, S.J., Bender, J.B. and Finno, C.J. (2003) Epidemiologic characteristics and management of polysaccharide storage myopathy in Quarter Horses. Am. J. vet. Res. 64, 1319-1327.
  • Fruen, B.R., Mickelson, J.R. and Louis, C.F. (1997) Dantrolene inhibition of sarcoplasmic reticulum Ca2+ release by direct and specific action at skeletal muscle ryanodine receptors. J. biol. Chem. 272, 26965-26971.
  • Harris, P. (1997) Equine rhabdomyolysis syndrome. In: Current Therapy in Equine Medicine, 4th edn., Ed: N.E.Robinson, W.B. Saunders Co., Philadelphia. pp 115-121.
  • Hodgson, D.R. (1985) Myopathies in the athletic horses. Comp. cont. Educ. pract. Vet. 7, S551-S555.
  • Inotsume, N., Higashi, A., Matsukane, I., Chikazawa, S., Nakano, M. and Matsuda, I. (1986) Relationship between serum concentrations and daily dose of dantrolene in cerebral-palsy patients. Pediatr. Pharmacol. 5, 253-259.
  • Klein, L. (1978) A review of 50 cases of post-operative myopathy in the horse - intrinsic and management factors affecting risk. Proc. Am. Ass. equine Practnrs. 24, 89-94.
  • Lentz, L.R., Valberg, S.J., Balog, E.M., Mickelson, J.R. and Gallant, E.M. (1999) Abnormal regulation of muscle contraction in horses with recurrent exertional rhabdomyolysis. Am. J. vet. Res. 60, 992-999.
  • Lentz, L.R., Valberg, S.J., Herold, L.V., Onan, G.W., Mickelson, J.R. and Gallant, E.M. (2002) Myoplasmic calcium regulation in myotubes from horses with recurrent exertional rhabdomyolysis. Am. J. vet. Res. 63, 1724-1731.
  • Lopez, J.R., Linares, N., Cordovez, G. and Terzic, A. (1995) Elevated myoplasmic calcium in exercise induced equine rhabdomyolysis. Eur. J. Physiol. 430, 293-295.
  • McGowan, C.M., Fordham, T. and Christley, R.M. (2002) Incidence and risk factors for exertional rhabdomyolysis in thoroughbred racehorses in the United Kingdom. Vet. Rec. 151, 23-26.
  • MacLeay, J.M., Sorum, S.A., Valberg, S.J., Marsh, W.E. and Sorum, M.D. (1999a) Epidemiologic analysis of factors influencing exertional rhabdomyolysis Thoroughbreds. Am. J. vet. Res. 60, 1562-1566.
  • MacLeay, J.M., Valberg, S.J., Sorum, S.A., Sorum, M.D., Kassube, T., Santschi, E.M., Mickelson, J.R. and Geyer, C.J. (1999b) Heritability of recurrent exertional rhabdomyolysis in Thoroughbred racehorses. Am. J. vet. Res. 60, 250-256.
  • MacLeay, J.M., Valberg, S.J., Pagan, J.D., Xue, J.L., De La Corte, F.D. and Roberts, J. (2000) Effect of ration and exercise on plasma creatine kinase activity and lactate concentration in Thoroughbred horses with recurrent exertional rhabdomyolysis. Am. J. vet. Res. 61, 1390-1395.
  • McKenzie, E.M. and Mosley, C.M. (2009) Dantrolene sodium prevents myopathy in horses undergoing hypotensive anesthesia. The American College of Vetinary Anaesthesiology 2009 Annual Meeting. Chicago, Illinois, USA. September 10, 2009. Available at: http://acva.org/professional/schol.asp.
  • McKenzie, E.C., Valberg, S.J., Godden, S.M., Finno, C.J. and Murphy, M.J. (2004) Effect of oral administration of dantrolene sodium on serum creatine kinase activity after exercise in horses with recurrent exertional rhabdomyolysis. Am. J. vet. Res. 65, 74-49.
  • McKenzie, E.C., Valberg, S.J., Godden, S.M., Pagan, J.D., MacLeay, J.M., Geor, R.J. and Carlson, G.P. (2003) Effect of dietary starch, fat, and bicarbonate content on exercise responses and serum creatine kinase activity in equine recurrent exertional rhabdomyolysis. J. vet. intern. Med. 17, 693-701.
  • Meyler, W.J., Bakker, H., Kok, J.J., Agoston, S. and Wesseling, H. (1981) The effect of dantrolene sodium in relation to blood levels in spastic patients after prolonged administration. J. Neurol. Neurosurg. Psychiatry 44, 334-339.
  • Morgan, K.G. and Bryant, S.H. (1977) The mechanism of action of dantrolene sodium. J. Pharmacol. expt. Ther. 201, 138-147.
  • Todi, F., Mendonca, M., Fenwick, J.D. and Yelle, C. (1988/1999) Determination of urine and plasma levels of dantrolene and metabolites in the horses after oral administration. In: Proceedings 41st and 42nd Meeting of Association of Official Racing Chemists. pp 212-220.
  • Valverde, A., Boyd, C.J., Dyson, D.H. and Pascoe, P.J. (1990) Prophylactic use of dantrolene associated with prolonged postanesthetic recumbency in a horse. J. Am. vet. med. Ass. 197, 1051-1053.
  • Waldron-Mease, E. (1978) Correlation of post-operative and exercise induced equine myopathy with the defect malignant hyperthermia. Proc. Am. Ass. equine Practnrs. 22, 95-99.
  • Waldron-Mease, E., Klein, L.V., Rosenberg, H. and Leitch, M. (1981) Malignant hyperthermia in a halothane-anesthetized horse. J. Am. vet. med. Ass. 179, 896-898.